Imbalance in superoxide dismutase/thioredoxin reductase activities in hypercholesterolemic subjects: Relationship with low density lipoprotein oxidation

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Augusti, Paula Rossini ^a,b   Ruviaro, Amanda Roggia ^c   Quatrin, Andréia ^c   Somacal, Sabrina ^c   Conterato, Greicy Michelle Marafiga ^c   Vicentini, Juliana Tanara ^c   Duarte, Marta Medeiros Frescura ^d   Emanuelli, Tatiana ^c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^d UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

Atherogenic index; Hypercholesterolemia; Oxidized low density lipoprotein; Superoxide dismutase; Thioredoxin reductase

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; AUTOANTIBODY; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 1;

ADULT; ARTICLE; ATHEROGENIC INDEX; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; LIPID BLOOD LEVEL; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; SCORING SYSTEM;

ADULT; AGED; ARYLDIALKYLPHOSPHATASE; AUTOANTIBODIES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; INFLAMMATION MEDIATORS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE 1;

EID: 84862501780     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-79     Document Type: Article

References (41)

1. Preventing coronary artery disease by lowering cholesterol levels: fifty years from bench to bedside. Steinberg D, Gotto AM, J Am Med Ass 1999 282 2043 2050 10.1001/jama.282.21.2043
2. Hipátese oxidativa da aterosclerose. Batlouni M, Arq Bras Cardiol 1997 68 55 63 9334462
3. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Packard RRS, Libby P, Clin Chem 2008 54 24 38 18160725 (Pubitemid 351182593)
4. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN, J Clin Invest 1998 101 1581 1590 10.1172/JCI1649 9541487 (Pubitemid 28198486)
5. Does paraoxonase play a role in susceptibility to cardiovascular disease?Mol. Aviram M, Med Today 1999 5 381 386 10.1016/S1357-4310(99)01546-4 (Pubitemid 29399986)
6. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Cai H, Harrison DG, Circ Res 2000 87 840 844 10.1161/01.RES.87.10.840 11073878
7. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Stralin P, Karlsson K, Johansson BO, Marklund SL, Arterioscler Thromb Vasc Biol 1995 15 2032 2036 10.1161/01.ATV.15.11.2032 7583586
8. Physiological functions of thioredoxin and thioredoxin reductase. Arnér ESJ, Holmgren A, Eur J Biochem 2000 267 6102 6109 10.1046/j.1432-1327.2000.01701.x 11012661
9. Thioredoxine reductase, a redoxactive selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma. Söderberg A, Sahaf B, Rosén A, Cancer Res 2000 60 2281 2289 10786696 (Pubitemid 30225195)
10. Serum thioredoxin and -tocopherol concentrations in patients with major risk factors. Kunihisa M, Chiharu K, Nakamura H, Makita T, Ishii K, Okuda N, Yodoi J, Sasayama S, Circ J 2005 69 291 294 10.1253/circj.69.291 15731533 (Pubitemid 40410183)
11. Serum thioredoxin (TRX) levels in patients with heart failure. Kishimoto C, Shioji K, Nakamura H, Nakayama Y, Yodoi J, Sasayama S, Jpn Circ J 2001 65 491 494 10.1253/jcj.65.491 11407728 (Pubitemid 32531539)
12. Decreased serum levels of thioredoxin in patients with coronary artery disease plus hyperhomocysteinemia is strongly associated with the disease severity. Wu Y, Yang L, Zhong L, Atherosclerosis 2010 212 351 355 10.1016/j.atherosclerosis.2010.06.002 20594554
13. Elevated circulating levels of thioredoxin and stress in chronic heart failure. Jekell A, Hossain A, Alehagen U, Dahlström U, Rose A, Eur J Heart Fail 2004 6 883 890 15556050 (Pubitemid 39536304)
14. Astaxanthin reduces oxidative stress, but not aortic damage in atherosclerotic rabbits. Augusti PR, Conterato GMM, Somacal S, Sobieski R, Quatrin A, Maurer L, Rocha MP, Denardin IT, Emanuelli T, J Cardiovasc Pharmacol Ther 2009 14 314 322 10.1177/1074248409350136 19846890
15. Soybean glycinin improves HDL-C and suppresses the effects of rosuvastatin on hypercholesterolemic rats. Fassini PG, Noda RW, Ferreira ES, Silva MA, Neves VA, Demonte A, Lipid Health Dis 2011 10 165 10.1186/1476-511X- 10-165
16. Nonenzymatic glucosylation of homologous LDL and albumin render them inununogenic in the guinea pig. Witztum JL, Steinbrecher UP, Fisher M, Kesaniemi A, Proc Natl Acad Set U S A 1983 80 2757 2761 10.1073/pnas.80.9.2757 (Pubitemid 13093388)
17. Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation or carbamylation: generation of antibodies specific for derivatized lysine. Steinbrecher UP, Fisher M, Witztum JL, Curtiss LK, Lipid Res 1984 25 1109 1116 (Pubitemid 15207094)
18. Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits. Wiklund O, Witztum JL, Carew TE, Pittman RC, Elam RL, Steinberget D, J Lipid Res 1987 28 1098 1109 3655562 (Pubitemid 17129791)
19. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Shoji T, Nishizawa Y, Fukumoto M, Shimamura K, Kimura J, Kanda H, Emoto M, Kawagishi T, Morii H, Atherosclerosis 2000 148 171 177 10.1016/S0021-9150(99)00218-X 10580183
20. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Yla-Herttuala S, Palinski W, Butler SW, Picard S, Steinberg D, Witztum JL, Arterioscler Thromb Vasc Biol 1994 14 32 40 10.1161/01.ATV.14.1.32
21. Hypercholesterolemia increases endothelial superoxide anion production. Ohara Y, Peterson TE, Harrison DG, J Clin Invest 1993 91 2546 2551 10.1172/JCI116491 8390482 (Pubitemid 23182507)
22. Astaxanthin prevents changes in the activities of thioredoxin reductase and paraoxonase in hypercholesterolemic rabbits. Augusti PR, Quatrin A, Somacal S, Conterato GMM, Sobieski R, Ruviaro AR, Maurer LH, Duarte MMF, Roehrs M, Emanuelli T, J Clin Biochem Nutr in press 10.3164/jcbn.11-74
23. Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters. Bambini-Junior V, Rodrigues L, Behr GA, Moreira JCF, Riesgo R, Gottfried C, Brain Res 2011 1408 8 16 21767826
24. Imbalance in SOD/CAT activities in rat skeletal muscles submitted to treadmill training exercise. Pinho RA, Andrades ME, Oliveira MR, Pirola AC, Zago MS, Silveira PCL, Dal-Pizzol F, Moreira JCF, Cell Biol Int 2006 30 848 853 10.1016/j.cellbi.2006.03.011 17011801 (Pubitemid 44573865)
25. Low paraoxonase activity predicts coronary events in the Caerphilly prospective study. Mackness B, Durrington P, McElduff P, Yarnell J, Azam N, Watt M, Mackness M, Circulation 2003 107 2775 2779 10.1161/01.CIR.0000070954.00271. 13 12756158 (Pubitemid 36705985)
26. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du B, Free Rad Biol Med 1999 26 892 904 10.1016/S0891-5849(98)00272-X 10232833 (Pubitemid 29198362)
27. Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis. Mackness B, Hunt R, Durrington PN, Mackness MI, Arterioscler Thromb Vasc Biol 1997 17 1233 1238 10.1161/01.ATV.17.7.1233 9261251 (Pubitemid 27329844)
28. High prevalence of low serum paraoxonase-1 in subjects with coronary artery disease. Jayakumari N, Thejaseebai G, J Clin Biochem Nutr 2009 45 278 284 10.3164/jcbn.08-255 19902017
29. Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia. Van Himbergen TM, Roest M, de Graaf J, Jansen EH, Hattori H, Kastelein JJ, Voorbij HA, Stalenhoef AF, Van Tits LJ, J Lipid Res 2005 46 445 451 15576850 (Pubitemid 43109780)
30. High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis. Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Ekindjian OG, Kahan A, Borderie D, Clin Chim Acta 2006 367 156 161 10.1016/j.cca.2005.12.006 16458876
31. Executive summary of the third report the National Cholesterol Education Program (Adults Treatment III). Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
32. Precipitation methods for quantification of lipoproteins. Bachorik PS, Albers JJ, Methods Enzymol 1996 129 78 100
33. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Friedewald WT, Levy RI, Fredrickson DS, Clin Chem 1972 18 499 502 4337382
34. Increasing oxidative stress with progressive hyperlipidemia in human: relation between malondialdehyde and atherogenic index. Yang R, Shi Y, Hao G, Li W, Le G, J Clin Biochem Nutr 2008 43 154 158 10.3164/jcbn.2008044 19015749
35. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Holvoet P, Stassen JM, Van Cleemput J, Collen D, Vanhaecke J, Arterioscler Thromb Vasc Biol 1998 18 100 107 10.1161/01.ATV.18.1. 100 9445262 (Pubitemid 28047605)
36. Autoantibodies against oxidized low density lipoprotein (OxLDL): characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL. Wu R, Lefvert AK, Clin Exp Immunol 1995 102 174 180 7554386
37. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Ohkawa H, Ohishi N, Yagi K, Anal Biochem 1979 95 351 358 10.1016/0003-2697(79)90738-3 36810 (Pubitemid 9194347)
38. Determination of carbonyl content in oxidatively modified proteins. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER, Method Enzymol 1990 186 464 478 (Pubitemid 20279989)
39. The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay for superoxide-dismutase. Misra HP, Fridovich I, J Biol Chem 1972 247 3170 3175 4623845
40. Thioredoxin and thioredoxin reductase. Holmgren A, Björnstedt M, Meth Enzymol 1995 252 199 208 7476354
41. Effects of atorvastatin therapy on hypercholesterolemic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine. Bolayirli IM, Aslan M, Balci H, Altug T, Hacibekiroglu M, Seven A, Life Sci 2007 81 121 127 10.1016/j.lfs.2007.04.027 17532348 (Pubitemid 46921173)